Roche Expects Chinese Drug Market To Reach $100 Billion By 2015
This article was originally published in PharmAsia News
During a visit to Beijing Sept. 7, Roche CEO Severin Schwann predicted that the Chinese pharmaceutical market would grow to more than $100 billion by 2015
You may also be interested in...
The US firm gets development and co-commercial rights to MORAb-202 for $650m up front. BMS joins AstraZeneca, Merck & Co. and Gilead in recent ADC deal-making.
The recently concluded BIO annual meeting included several sessions focused on the practice of business development. In this extra edition of our BIO 2021 notebook, Scrip collected observations about best practices for partnerships.
The company’s rollout plans for Ayvakit appear similar to its approach when it marketed the drug for GIST, with an education plan to help boost sales.